These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 5138389)

  • 21. [Disturbance of the intensity of secretion and chemical composition of bile in liver dystrophy induced by carbon tetrachloride].
    Drogovoz SM
    Vopr Med Khim; 1971; 17(4):397-400. PubMed ID: 5317623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The efficacy of hepatoprotective agents in experimental chronic hepatitis].
    Saratikov AS; Vengerovskiĭ ; Baturina NO; Chuchalin VS
    Eksp Klin Farmakol; 1996; 59(1):24-6. PubMed ID: 8704626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of ethonium on the status of the liver glutathione system in toxic hepatitis].
    Meshchishen IF
    Farmakol Toksikol; 1989; 52(3):80-2. PubMed ID: 2792361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The characteristics of the action of polyphytochol on the course of experimental hepatitis and cholecystitis].
    Ubeeva IP; Sambueva ZG; Azhunova TA; Nikolaev SM
    Farmakol Toksikol; 1990; 53(2):43-5. PubMed ID: 2369954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatoprotective properties of liquid extract of Rhodiola rosea].
    Iaremiĭ IN; Grigor'eva NF
    Eksp Klin Farmakol; 2002; 65(6):57-9. PubMed ID: 12596536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytophotometric study of DNA in rabbit liver cells during experimental treatment of chronic hepatitis and liver cirrhosis.
    Leont'eva LI; Sherudilo AI; Iakobson GS
    Tsitologiia; 1971 May; 13(5):664-7. PubMed ID: 5561714
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of acetylcysteine on the antioxidant system in an experimental toxic lesion of the liver].
    Gonskiĭ IaI; Korda MM; Klishch IN
    Farmakol Toksikol; 1991; 54(5):44-6. PubMed ID: 1800148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of enteric oxygen therapy on the functional state of the liver in acute dystrophy].
    Skakun NP; Nestorovich IaM
    Biull Eksp Biol Med; 1977 Oct; 84(10):419-21. PubMed ID: 912053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The antioxidant properties of parmidine in a toxic lesion of the liver].
    Riabkov AN; Uzbekova DG; Artem'eva GB; Nikulin AA
    Farmakol Toksikol; 1991; 54(6):35-7. PubMed ID: 1804692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of sirepar on the functional state of the liver in experimental toxic hepatitis caused by carbon tetrachloride].
    Oleĭnik AN; Skakun LN
    Vrach Delo; 1975 Jun; (6):13-4. PubMed ID: 1154722
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bile-secreting function of the liver during combined administration of pyridoxine with glucose in acute experimental hepatitis].
    Pasechnik IKh
    Farmakol Toksikol; 1966; 29(2):192-6. PubMed ID: 6000345
    [No Abstract]   [Full Text] [Related]  

  • 32. [New hepatoprotective agents of natural origin].
    Saratikov AS; Vengerovskiĭ AI
    Eksp Klin Farmakol; 1995; 58(1):8-11. PubMed ID: 7787707
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of enteric oxygen therapy and vitamin E on the secretion and chemical composition of bile in experimental dystrophy].
    Skakun NP; Nestorovich IaM
    Vopr Med Khim; 1977; 23(4):558-62. PubMed ID: 919380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of vitamin E and sodium selenite in experimental hepatic dystrophy].
    Skakun NP; Nesterovich IaM
    Farmakol Toksikol; 1977; 40(4):434-8. PubMed ID: 902744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of B.S.P. metabolites and some histo-enzymologic modifications under the influence of aspartic acid].
    Barbarino F; Cotutiu C; Tapalaga D; Nicoara A
    Rev Int Hepatol; 1967 May; 17(6):491-504. PubMed ID: 4296788
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of nerobol on the secretory and excretory function of the liver in rats with experimental hepatitis].
    Doroshenko NM
    Fiziol Zh (1978); 1980; 26(2):275-7. PubMed ID: 7364094
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacological aspects of S-adenosyl-L-methionone in hepatology. (A) Biochemical signs. (B) Acute, chronic and fetal toxicity. (C) Biochemical and morphohistochemical changes in control rats and rats treated with S-adenosyl-L-methionine after experimental poisoning with various agents].
    Stramentinoli G; Pezzoli C; Catto E
    Minerva Med; 1975 May; 66(33):1541-62. PubMed ID: 1143691
    [No Abstract]   [Full Text] [Related]  

  • 38. [The joint use of prednisolone and phospholipid-containing hepatoprotectors in experimental chronic hepatitis].
    Vengerovskiĭ AI; Golovina EL; Kovalenko MIu; Chuchalin VS; Saprykina EV; Sosnina NV; Burkova VN; Saratikov AS
    Eksp Klin Farmakol; 1999; 62(2):28-30. PubMed ID: 10340125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilirubin metabolism in experimental liver injury.
    Garay EA; Campa JP
    J Lab Clin Med; 1968 Oct; 72(4):582-91. PubMed ID: 5677306
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of phytoecdysteroids on the bile-secretory function of the normal liver and in experimental hepatitis].
    Syrov VN; Nabiev AN; Sultanov MB
    Farmakol Toksikol; 1986; 49(3):100-3. PubMed ID: 3720929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.